{
    "nctId": "NCT06567353",
    "briefTitle": "A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases",
    "officialTitle": "A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Neoplasms, Liver Neoplasms, Metastasis",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 10,
    "primaryOutcomeMeasure": "Anti-tumor immune response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age 18-75 years, female gender;\n2. Pathologically confirmed breast cancer liver metastases, in patients who are unable to tolerate or refuse surgical resection;\n3. The number of lesions \u2264 3, with any single lesion diameter \u2264 4cm;\n4. At least an interval of 1 month since the last local treatment;\n5. Child-Pugh class A or B;\n6. ECOG PS score \u22642, with an expected survival of \\>3 months.\n\nExclusion Criteria:\n\n1. Liver function Child-Pugh class C;\n2. Systemic widespread metastasis, with an expected survival of \\< 3 months;\n3. History of esophageal (gastric fundus) variceal bleeding within the past month;\n4. Dysfunction or failure of vital organs;\n5. Presence of an active infection;\n6. Irreparable coagulation abnormality;\n7. Refractory massive ascites, pleural effusion or cachexia;\n8. Pregnancy, altered consciousness or patients unable to cooperate with treatment;\n9. Previously participated in other clinical studies and still within the follow-up period;\n10. Any other factors deemed inappropriate for inclusion or that may affect the patient's participation in the study, as determined by the investigator.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}